Status:
UNKNOWN
The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Recurrence
Metastasis
Eligibility:
All Genders
20+ years
Brief Summary
HNSCC is the 4th highest incidence of cancer and 6th of cancer death of the males in Taiwan. Because the patients were mainly middle-aged male, the disease eventually resulted in a huge loss of labor ...
Detailed Description
1. Establish a protocol and a practical platform to longitudinally isolate, enumerate CTCs in patients with HPV+-head and neck cancer during the treatment course. 2. Elucidate the clinical significanc...
Eligibility Criteria
Inclusion
- histologically or cytopathologically proven head and neck squamous cell carcinoma Age ≥ 20 years. Measurable or evaluable disease according to Response Evaluation Criteria In Solid Tumors(RECIST) criteria.
- Ability to sign informed consent.
Exclusion
- Prior cancers within 5 years, except for non-melanoma skin cancers, and in situ cervical cancers.
- Inability to completely with study and/or follow-up procedures.
Key Trial Info
Start Date :
July 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02791607
Start Date
July 1 2015
End Date
June 1 2019
Last Update
August 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taoyuan District, Taiwan, 333